Fairfield Financial Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-200
Closed -$3.04K 322
2022
Q1
$3.04K Buy
+200
New +$3.05K ﹤0.01% 275

Other funds holding NPTN

Fairfield Financial Advisors's NPTN Position: Q2 2022 in Review

Fairfield Financial Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 200 shares — an estimated $3.04K sold.

Fairfield Financial Advisors first reported a position in NPTN in Q1 2022 and held it in 1 quarter. The position peaked at $3.04K in Q1 2022. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.

  • Fairfield Financial Advisors reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
  • Fairfield Financial Advisors sold 200 NEOPHOTONICS CORP shares in Q2 2022, an estimated $3.04K.
  • Fairfield Financial Advisors first reported a position in NEOPHOTONICS CORP in Q1 2022 and held it in 1 quarter.
  • Fairfield Financial Advisors's NEOPHOTONICS CORP position peaked at $3.04K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.

Based on Fairfield Financial Advisors's 13F filing for Q2 2022, filed 7 Oct 2024.